Halozyme Therapeutics, Inc. (HALO)

71.71 +1.28 (+1.82%) USD  |  NASDAQ  |  Jan 21, 16:00
71.71 0.00 (0.00%) After-Hours: 20:00
More

Halozyme Therapeutics EBIT (Quarterly)

EBIT (Quarterly) Chart

View EBIT (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (Quarterly) Range, Past 5 Years

View EBIT (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (Quarterly) Benchmarks

View EBIT (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade